Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1984

1.

Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.

Parikh PB, Jeremias A, Naidu SS, Brener SJ, Lima F, Shlofmitz RA, Pappas T, Marzo KP, Gruberg L.

Catheter Cardiovasc Interv. 2012 Sep 1;80(3):352-7. doi: 10.1002/ccd.23394. Epub 2012 May 4.

PMID:
22566286
2.

Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention.

Nikolsky E, Mehran R, Turcot D, Aymong ED, Mintz GS, Lasic Z, Lansky AJ, Tsounias E, Moses JW, Stone GW, Leon MB, Dangas GD.

Am J Cardiol. 2004 Aug 1;94(3):300-5.

PMID:
15276092
3.

Chronic Kidney Disease in the Second-Generation Drug-Eluting Stent Era: Pooled Analysis of the Korean Multicenter Drug-Eluting Stent Registry.

Lee JM, Kang J, Lee E, Hwang D, Rhee TM, Park J, Kim HL, Lee SE, Han JK, Yang HM, Park KW, Na SH, Kang HJ, Koo BK, Kim HS.

JACC Cardiovasc Interv. 2016 Oct 24;9(20):2097-2109. doi: 10.1016/j.jcin.2016.06.051. Epub 2016 Sep 28.

4.
5.

Chronic kidney disease and the risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents.

Miao Y, Yu-Jie Z, Zhi-Jian W, Dong-Mei S, Yu-Yang L, Ying-Xin Z, Fei G, Shi-Wei Y, De-An J.

Catheter Cardiovasc Interv. 2012 Sep 1;80(3):361-7. doi: 10.1002/ccd.23464. Epub 2012 Mar 14.

PMID:
22419375
6.

Effects of statin treatment in patients with coronary artery disease and chronic kidney disease.

Kaneko H, Yajima J, Oikawa Y, Tanaka S, Fukamachi D, Suzuki S, Sagara K, Otsuka T, Matsuno S, Funada R, Kano H, Uejima T, Koike A, Nagashima K, Kirigaya H, Sawada H, Aizawa T, Yamashita T.

Heart Vessels. 2014 Jan;29(1):21-8. doi: 10.1007/s00380-013-0325-2. Epub 2013 Feb 21.

7.

Association of chronic renal insufficiency with in-hospital outcomes after percutaneous coronary intervention.

Gupta T, Paul N, Kolte D, Harikrishnan P, Khera S, Aronow WS, Mujib M, Palaniswamy C, Sule S, Jain D, Ahmed A, Cooper HA, Frishman WH, Bhatt DL, Fonarow GC, Panza JA.

J Am Heart Assoc. 2015 Jun 16;4(6):e002069. doi: 10.1161/JAHA.115.002069.

8.

The impact of renal function on the long-term clinical course of patients who underwent percutaneous coronary intervention.

Papafaklis MI, Naka KK, Papamichael ND, Kolios G, Sioros L, Sclerou V, Katsouras CS, Michalis LK.

Catheter Cardiovasc Interv. 2007 Feb 1;69(2):189-97.

PMID:
17253600
9.
10.

Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease.

Ashrith G, Lee VV, Elayda MA, Reul RM, Wilson JM.

Am J Cardiol. 2010 Aug 1;106(3):348-53. doi: 10.1016/j.amjcard.2010.03.037. Epub 2010 Jun 18.

PMID:
20643244
11.

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).

Marui A, Kimura T, Nishiwaki N, Mitsudo K, Komiya T, Hanyu M, Shiomi H, Tanaka S, Sakata R; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.

Am J Cardiol. 2014 Aug 15;114(4):555-61. doi: 10.1016/j.amjcard.2014.05.034. Epub 2014 Jun 6.

PMID:
24996550
12.

The impact of previous revascularization on clinical outcomes in patients undergoing primary percutaneous coronary intervention.

Bench TJ, Parikh PB, Jeremias A, Brener SJ, Naidu SS, Shlofmitz RA, Pappas T, Marzo KP, Gruberg L.

J Invasive Cardiol. 2013 Apr;25(4):166-9.

13.

Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries.

Yan BP, Clark DJ, Buxton B, Ajani AE, Smith JA, Duffy SJ, Shardey GC, Skillington PD, Farouque O, Yii M, Yap CH, Andrianopoulos N, Brennan A, Dinh D, Reid CM; Australasian Society of Cardiac and Thoracic Surgeons (ASCTS); Melbourne Interventional Group (MIG).

Heart Lung Circ. 2009 Jun;18(3):184-90. doi: 10.1016/j.hlc.2008.10.005. Epub 2009 Mar 5.

PMID:
19268632
14.

Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry.

Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, Kosiborod M, Amin AP, Messenger JC, Rumsfeld JS, Spertus JA.

JACC Cardiovasc Interv. 2014 Jan;7(1):1-9. doi: 10.1016/j.jcin.2013.06.016.

15.

Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease.

Reddan DN, Szczech LA, Tuttle RH, Shaw LK, Jones RH, Schwab SJ, Smith MS, Califf RM, Mark DB, Owen WF Jr.

J Am Soc Nephrol. 2003 Sep;14(9):2373-80.

16.

Outcomes in patients with renal impairment undergoing percutaneous coronary intervention and implantation of the Endeavor zotarolimus-eluting stent: 1- and 2-year data from the E-Five Registry.

Rothman MT, Jain AK; E-Five Registry Investigators.

Catheter Cardiovasc Interv. 2012 Nov 15;80(6):885-92. doi: 10.1002/ccd.23484. Epub 2012 Apr 19.

PMID:
22517785
17.

Impact of aging on the clinical outcomes of Japanese patients with coronary artery disease after percutaneous coronary intervention.

Kaneko H, Yajima J, Oikawa Y, Tanaka S, Fukamachi D, Suzuki S, Sagara K, Otsuka T, Matsuno S, Funada R, Kano H, Uejima T, Koike A, Nagashima K, Kirigaya H, Sawada H, Aizawa T, Yamashita T.

Heart Vessels. 2014 Mar;29(2):156-64. doi: 10.1007/s00380-013-0339-9. Epub 2013 Apr 4.

18.

QT prolongation is an independent predictor of mortality in end-stage renal disease.

Hage FG, de Mattos AM, Khamash H, Mehta S, Warnock D, Iskandrian AE.

Clin Cardiol. 2010 Jun;33(6):361-6. doi: 10.1002/clc.20768.

19.

Outcomes for patients with ST-elevation myocardial infarction in hospitals with and without onsite coronary artery bypass graft surgery: the New York State experience.

Hannan EL, Zhong Y, Racz M, Jacobs AK, Walford G, Cozzens K, Holmes DR, Jones RH, Hibberd M, Doran D, Whalen D, King SB 3rd.

Circ Cardiovasc Interv. 2009 Dec;2(6):519-27. doi: 10.1161/CIRCINTERVENTIONS.109.894048. Epub 2009 Nov 10.

20.

Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.

Halkin A, Selzer F, Marroquin O, Laskey W, Detre K, Cohen H.

J Invasive Cardiol. 2006 Dec;18(12):577-83.

PMID:
17197706

Supplemental Content

Support Center